Health Status After Treatment for Coronary Artery Disease and Type 2 Diabetes Mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial
Author(s) -
Maria M. Brooks,
ShengChia Chung,
Tarek Helmy,
William B. Hillegass,
Jorge Escobedo,
Kathryn Melsop,
Elaine Massaro,
Robert D. McBane,
Pamela Hyde,
Mark A. Hlatky
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.912642
Subject(s) - medicine , revascularization , angioplasty , randomized controlled trial , percutaneous coronary intervention , diabetes mellitus , cardiology , coronary artery disease , randomization , bypass surgery , surgery , myocardial infarction , artery , endocrinology
Health status is a key outcome for comparing treatments, particularly when mortality does not differ significantly.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom